BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lai S, Lin C, Liao K. Synergistic effect of oral corticosteroids use on risk of hepatocellular carcinoma in high risk populations. European Journal of Internal Medicine 2018;52:73-7. [DOI: 10.1016/j.ejim.2018.03.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lai SW. Risk factors for hepatocellular carcinoma. Cancer 2019;125:482. [PMID: 30500069 DOI: 10.1002/cncr.31802] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Yi SW, Choi JS. Reply to Risk factors for hepatocellular carcinoma. Cancer 2019;125:483. [PMID: 30500071 DOI: 10.1002/cncr.31801] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Liao KF, Lai HC, Lin CL, Lai SW. Letter: cohort study examining the association between proton pump inhibitor therapy and risk of hepatocellular carcinoma in Taiwan. Aliment Pharmacol Ther 2018;48:689-90. [PMID: 30132939 DOI: 10.1111/apt.14905] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]